$3.6 M

Immudyne Revenue Q2, 2018
Immudyne Gross profit (Q2, 2018)2.8 M
Immudyne Gross profit margin (Q2, 2018), %75.6%
Immudyne Net income (Q2, 2018)-8.6 K
Immudyne EBIT (Q2, 2018)-876.8 K
Immudyne Cash, 30-Jun-2018691.2 K

Immudyne Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

808.4k714.2k1.2m5.2m

Revenue growth, %

(12%)71%330%

Cost of goods sold

181.3k172.9k247.8k1.9m

Gross profit

627.1k541.3k971.1k3.3m

Gross profit Margin, %

78%76%80%63%

R&D expense

23.9k

General and administrative expense

393.4k373.7k331.4k1.0m

Operating expense total

393.4k373.7k355.3k1.0m

Interest expense

3.4k4.7k37.5k48.6k

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

277.4k279.9k1.6m1.2m1.4m424.5k1.6m3.6m

Cost of goods sold

89.5k74.0k1.3m701.0k942.7k203.4k355.5k890.2k

Gross profit

187.9k205.9k303.1k526.3k441.7k221.1k1.3m2.8m

Gross profit Margin, %

68%74%18%43%32%52%78%76%

General and administrative expense

63.9k57.6k98.4k79.5k205.0k127.2k357.4k554.4k

Operating expense total

63.9k57.6k98.4k79.5k205.0k127.2k1.8m1.5m3.6m

EBIT

17.9k(105.1k)(207.7k)(279.3k)(876.8k)

EBIT margin, %

6%(6%)(15%)(17%)(24%)

Interest expense

8.2k14.4k3.1k2.8k10.0k649.4k6.5k57.5k

Net Income

8.1k(108.2k)(217.7k)(651.9k)640.0k(8.6k)

Immudyne Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

155.1k75.5k233.0k182.6k

Accounts Receivable

77.5k15.0k444.7k

Inventories

86.2k41.0k61.1k160.3k

Current Assets

450.7k131.5k448.5k789.8k

Total Assets

551.4k175.2k448.5k

Accounts Payable

185.4k274.3k167.5k752.9k

Short-term debt

27.2k100.0k

Current Liabilities

325.6k301.5k267.5k1.2m

Long-term debt

27.2k100.0k100.0k

Total Debt

54.4k200.0k100.0k

Additional Paid-in Capital

8.0m8.1m8.4m9.1m

Total Equity

195.5k181.0k(361.7k)

Debt to Equity Ratio

1.1 x-0.3 x

Debt to Assets Ratio

0.3 x0.4 x

Financial Leverage

2.8 x2.5 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

61.1k90.0k70.1k79.5k73.9k203.6k235.5k473.9k381.1k229.8k691.2k

Accounts Receivable

299.3k451.1k474.9k555.7k85.8k64.0k

Inventories

83.5k54.9k43.5k21.5k39.4k138.5k179.3k130.5k136.9k601.2k507.2k

Current Assets

229.9k255.5k187.0k236.4k245.0k641.5k865.8k1.1m1.1m1.3m1.2m1.5m

Total Assets

302.2k313.5k216.5k251.6k245.0k1.8m

Accounts Payable

242.6k259.1k251.5k314.2k275.4k337.0k421.6k408.2k562.2k318.4k446.4k

Short-term debt

67.2k91.9k98.5k106.5k100.0k100.0k

Current Liabilities

265.8k326.3k343.4k412.7k381.9k437.0k521.6k622.3k2.4m777.0k318.4k511.5k

Long-term debt

67.2k91.9k98.5k106.5k100.0k100.0k214.1k

Additional Paid-in Capital

8.0m8.0m8.1m8.1m8.1m8.4m8.8m9.0m9.4m11.2m11.1m11.9m

Total Equity

14.5k204.5k344.1k457.1k

Financial Leverage

20.8 x

Immudyne Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Depreciation and Amortization

57.0k57.0k43.7k

Accounts Receivable

(27.8k)62.5k(139.5k)(2.2k)

Inventories

(22.8k)45.2k(20.0k)(99.2k)

Accounts Payable

(1.7k)89.0k(22.0k)585.4k

Cash From Operating Activities

33.4k(295.1k)

Short-term Borrowings

94.2k67.0k305.0k200.0k

Cash From Financing Activities

315.2k(113.0k)325.4k357.5k

Interest Paid

29.0k13.7k

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

8.1k(108.2k)(217.7k)(651.9k)640.0k(8.6k)

Depreciation and Amortization

28.5k43.7k10.5k

Accounts Receivable

(120.4k)(116.8k)(144.9k)(296.6k)(276.9k)2.3k

Inventories

19.5k1.6k(77.4k)(118.2k)(69.5k)23.3k80.1k174.0k

Accounts Payable

39.9k1.1k169.5k254.2k240.7k(188.5k)(73.4k)(29.5k)

Cash From Operating Activities

(56.4k)(80.3k)65.9k(228.2k)

Cash From Investing Activities

190.0k241.4k

Short-term Borrowings

130.0k205.0k150.0k

Long-term Borrowings

(167.5k)(167.5k)

Cash From Financing Activities

60.5k78.7k92.8k79.1k352.6k671.8k695.9k(167.5k)536.5k

Interest Paid

18.6k24.5k3.1k5.8k8.6k3.6k4.4k4.4k
Report incorrect company information